cabazitaxel safe and effective in mcrpc
Published 5 years ago • 546 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
0:34
discussing the safety profile of cabazitaxel in mcrpc
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
2:06
mcrpc: cabazitaxel re-challenge
-
4:50
card trial: cabazitaxel after ar-targeted therapy in mcspc
-
1:53
nicholas vogelzang, md, explains how cabazitaxel should be used in various lines of treatment in mpc
-
3:16
counseling patients with mcrpc
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
0:50
checkmate 650: nivolumab ipilimumab, ipilimumab alone, or cabazitaxel in mcrpc
-
3:59
researcher comment: cabazitaxel a new third-line option in mcrpc | ronald de wit
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
3:13
treatment options in metastatic prostate cancer
-
7:09
cabazitaxel use in metastatic prostate cancer
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer